These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 183322)
21. [The when and how of therapy for hyperlipoproteinemia]. Mordasini R Schweiz Med Wochenschr; 1978 Jan; 108(4):113-9. PubMed ID: 203028 [TBL] [Abstract][Full Text] [Related]
22. Diet and drug treatment of hyperlipidemia and atherosclerosis. Kuo PT Ann Clin Lab Sci (1971); 1972; 2(4):322-4. PubMed ID: 4342101 [No Abstract] [Full Text] [Related]
23. Clofibrate and related compounds in hyperlipoproteinaemia. A review. Gustafson A Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983 [No Abstract] [Full Text] [Related]
26. Effect of clofibrate on the composition of very low and low density lipoprotein subfractions in type III hyperlipoproteinaemia. Ballantyne D; Ballantyne FC; Stromberg P; Third JL; Bedford DK Clin Chim Acta; 1978 Feb; 83(1-2):117-22. PubMed ID: 202421 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)]. von Löwis P; Klemens UH Dtsch Med Wochenschr; 1973 Dec; 98(49):2328-33. PubMed ID: 4357927 [No Abstract] [Full Text] [Related]
28. Effect of vitamin E on serum cholesterol and triglycerides in hyperlipidemic patients treated with diet and clofibrate. Leonhardt ET Am J Clin Nutr; 1978 Jan; 31(1):100-5. PubMed ID: 202160 [TBL] [Abstract][Full Text] [Related]
29. Clofibrate in type II hyperlipoproteinemia. Ditzel J; Bang HO Acta Med Scand; 1976; 200(1-2):55-58. PubMed ID: 183462 [TBL] [Abstract][Full Text] [Related]
31. Dietary control of hyperlipidaemia. Dietitians in the EEC: 2. Republic of Ireland. J Hum Nutr; 1977 Feb; 31(1):11-8. PubMed ID: 194979 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)]. Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201 [TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting. Millett F; Sielski J; Stoll H; Alston N; Gail S PA J; 1976; 6(2):54-9. PubMed ID: 10235781 [No Abstract] [Full Text] [Related]
34. Therapy of hyperlipidemic states. Havel RJ; Kane JP Annu Rev Med; 1982; 33():417-33. PubMed ID: 7044276 [No Abstract] [Full Text] [Related]
35. Diet and drug therapy for hyperlipoproteinemia. Maha GE Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828 [No Abstract] [Full Text] [Related]
37. Gemfibrozil treatment: a comparison with clofibrate. Howard AN; Ghosh P Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609 [TBL] [Abstract][Full Text] [Related]
38. Treatment of the hyperlipidemic states with special emphasis on the place of cholestyramine in therapy. Casdorph HR Angiology; 1970 Nov; 21(10):654-60. PubMed ID: 5480092 [No Abstract] [Full Text] [Related]
39. Dose-response effect of single and combined clofibrate (Atromidin) and niceritrol (Perycit) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia. Olsson AG; Orö L; Rössner S Atherosclerosis; 1975; 22(1):91-101. PubMed ID: 1098680 [TBL] [Abstract][Full Text] [Related]
40. Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial. Carlson LA; Olsson AG Lancet; 1979 Apr; 1(8121):869-70. PubMed ID: 86108 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]